top of page

Epilepsy pipeline conference

August 27-28,2020

Come Join Us!


Interested in epilepsy treatment, therapeutic innovation, and product development? Join us at the virtual Epilepsy Foundation Pipeline Conference, August 27-28, 2020 

Register here!

The Epilepsy Foundations Pipeline Conference brings together decision makers with a stake in the field of epilepsy treatment, therapeutic innovation, and product development.

Join NeuCyte's Presentation

NeuCyte's Platform

Based on its proprietary technology for generating human iPSC-derived induced neuronal cells, NeuCyte has developed an in vitro human neural platform for complex electrophysiological and morphological readouts suited for target identification and validation, efficacy testing, and neurotoxicity assessment. Using patient-derived and genetically engineered defined neural cell types, NeuCyte builds unique cell-based assays for modeling neurological and neurodegenerative disorders.

This presentation will be included in Session V, Day 2.

Date: August 28, 2020 

Session Title: Screening

Session Time: 9:05 am


Thomas Portmann PhD,

Head of Research, NeuCyte

NeuCyte is committed to developing epilepsy treatment. For more information about our drug discovery programs and our first-in-class lead epilepsy compound NC-201, please visit:

bottom of page